Evaluation of the Etest method for determining voriconazole susceptibilities of 312 clinical isolates of Candida species by using three different agar media

Journal of Clinical Microbiology

Volumn 38, Issue 10, 2000, Pages 3715-3717

  Pfaller, M A ^a   Messer, S A ^a   Houston, A ^a   Mills, K ^a   Bolmstrom, A ^a   Jones, R N ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGAR; ANTIBIOTIC AGENT; GLUCOSE; VORICONAZOLE;

ANALYTIC METHOD; ARTICLE; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA GUILLIERMONDII; CANDIDA KRUSEI; CANDIDA LUSITANIAE; CANDIDA PARAPSILOSIS; CANDIDA TROPICALIS; CONTROLLED STUDY; CULTURE MEDIUM; INTERMETHOD COMPARISON; MICROBIOLOGICAL EXAMINATION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PERFORMANCE; PRIORITY JOURNAL;

CANDIDA; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA GUILLIERMONDII; CANDIDA KRUSEI; CANDIDA LUSITANIAE; CANDIDA PARAPSILOSIS; CANDIDA TROPICALIS; CLAVISPORA LUSITANIAE; ISSATCHENKIA ORIENTALIS; PICHIA GUILLIERMONDII;

EID: 0033775443     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/jcm.38.10.3715-3717.2000     Document Type: Article

References (20)

1. Quality control limits for broth microdilution susceptibility tests of ten antifungal agents
2. Antifungal susceptibility testing using the Etest: Comparison with the broth macrodilution technique
3. Comparison of Etest and National Committee for Clinical Laboratory Standards broth macrodilution method for azole antifungal testing
4. Evaluation of the Etest system versus a microtitre broth method for antifungal susceptibility testing of yeasts against fluconazole and itraconazole
5. In vitro activity of the new triazole voriconazole (UK-109,496) against opportunistic filamentous and dimorphic fungi and common and emerging yeast pathogens
6. Interlaboratory evaluation of Etest method for testing antifungal susceptibilities of pathogenic yeasts to five antifungal agents by using Casitone agar and solidified RPMI 1640 medium with 2% glucose
7. Antifungal agents and susceptibility tests
8. Antibacterial susceptibility tests: Dilution and disk diffusion methods
9. Detection of resistance to amphotericin B among Cryptococcus neoformans clinical isolates: Performance of three different media assessed by using Etest and National Committee for Clinical Laboratory Standards M27-A methodologies
10. In vitro activities of voriconazole (UK-109,496) and four other antifungal agents against 394 clinical isolates of Candida spp.
11. Antifungal susceptibility testing: Progress and future developments
12. Evaluation of the Etest method for determining fluconazole susceptibilities of 402 clinical yeast isolates by using three different agar media
13. Evaluation of Etest for determining in vitro susceptibility of yeast isolates to amphotericin B
14. In vitro susceptibilities of Candida bloodstream isolates to the new triazole antifungal agents BMS-207147, Sch 56592, and voriconazole
15. In vitro activities of voriconazole, fluconazole, and itraconazole against 566 clinical isolates of Cryptococcus neoformans from the United States and Africa
16. In vitro activities of voriconazole (UK-109,496) against fluconazole-susceptible and -resistant Candida albicans isolates from oral cavities of patients with human immunodeficiency virus infection
17. Comparison of Etest and broth microdilution methods for antifungal drug susceptibility testing of molds
18. Comparison of Etest and National Committee for Clinical Laboratory Standards broth macrodilution method for antifungal susceptibility testing: Enhanced ability to detect amphotericin B-resistant Candida isolates
19. Candida, Cryptococcus, and other yeasts of medical importance